$REFI
Chicago Atlantic Real Estate Finance, Inc. Stock $refi

$refi Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000095017024053919 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q4
Revenue	$15.02M	$15.34M	$16.60M
YoY Change	9.94%	2.89%	3.78%
Cost Of Revenue	$1.839M	$2.104M	$1.691M
YoY Change	84.83%	30.02%	37.33%
Gross Profit	$13.18M	$13.24M	$14.91M
YoY Change	-3.52%	-11.22%	0.98%
Gross Profit Margin	87.76%	86.28%	89.81%
Selling, General & Admin	$4.275M	$15.59M	$5.763M
YoY Change	10.13%	-23.11%	14.72%
% of Gross Profit	32.43%	117.78%	38.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$3.999M	$15.59M	$5.510M
YoY Change	-20.34%	269.73%	-26.61%
Operating Profit	$9.184M	-$2.354M	$9.398M
YoY Change	6.26%	-122.01%	29.52%
Interest Expense	$1.839M	$2.104M
YoY Change	111.03%	46.01%
% of Operating Profit	20.02%
Other Income/Expense, Net
YoY Change
Pretax Income	$9.184M	$8.730M	$9.398M
YoY Change	6.26%	-18.35%	29.52%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%	0.0%
Net Earnings	$9.184M	$8.730M	$9.398M
YoY Change	6.26%	-18.35%	29.52%
Net Earnings / Revenue	61.14%	56.91%	56.62%
Basic Earnings Per Share	$0.47	$0.48
Diluted Earnings Per Share	$0.46	$0.47	$0.51
COMMON SHARES
Basic Shares Outstanding	19.10M	18.20M	18.18M shares
Diluted Shares Outstanding	19.89M	18.64M

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.071M	$6.904M	$7.898M
YoY Change	-60.76%	48.77%	38.18%
Cash & Equivalents	$7.071M	$6.900M	$7.900M
Short-Term Investments
Other Short-Term Assets	$838.9K	$192.4K	$107.2K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables			$327.8K
Total Short-Term Assets	$8.539M	$12.24M	$8.711M
YoY Change	-55.69%	86.94%	29.36%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$0.00	$842.3K
YoY Change	-100.0%
Other Assets	-$5.081M	-$5.356M	-$4.973M
YoY Change	-0.8%	32.18%	26.18%
Total Long-Term Assets	$378.0M	$371.4M	$350.5M
YoY Change	21.42%	17.41%	4.15%
TOTAL ASSETS
Total Short-Term Assets	$8.539M	$12.24M	$8.711M
Total Long-Term Assets	$378.0M	$371.4M	$350.5M
Total Assets	$386.5M	$383.7M	$359.2M
YoY Change	16.92%	18.82%	4.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.542M	$1.343M	$1.135M
YoY Change	8.9%	39.57%	7.3%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.57M	$12.17M	$18.25M
YoY Change	5.45%	3.41%	1.52%
LONG-TERM LIABILITIES
Long-Term Debt	$76.75M	$81.25M	$66.00M
YoY Change	78.49%	116.67%	13.79%
Other Long-Term Liabilities	$4.442M	$4.275M	$3.126M
YoY Change	128.54%	186.85%	-4.27%
Total Long-Term Liabilities	$81.19M	$85.52M	$69.13M
YoY Change	80.65%	119.35%	12.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.57M	$12.17M	$18.25M
Total Long-Term Liabilities	$81.19M	$85.52M	$69.13M
Total Liabilities	$93.77M	$97.69M	$87.37M
YoY Change	64.88%	92.47%	10.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.394M	-$6.089M	-$5.812M
YoY Change	120.66%	104.14%	13.07%
Common Stock	$299.1M	$292.0M	$277.7M
YoY Change	164473.47%	161354.13%	156897.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$292.7M	$286.0M	$271.9M
YoY Change
Total Liabilities & Shareholders Equity	$386.5M	$383.7M	$359.2M
YoY Change	16.92%	18.82%	4.65%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$9.184M	$8.730M	$9.398M
YoY Change	6.26%	-18.35%	29.52%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$6.211M	$6.918M	$15.50M
YoY Change	-39.17%	306.44%	235.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$2.855M	-$18.72M	-$10.74M
YoY Change	-154.93%	-173.93%	137.63%
Cash From Investing Activities	-$2.855M	-$18.72M	-$10.74M
YoY Change	-154.93%	-173.93%	137.63%
FINANCING ACTIVITIES
Cash Dividend Paid		$13.87M
YoY Change		2.82%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.189M	10.81M	-5.568M
YoY Change	57.13%	-138.46%	49.54%
NET CHANGE
Cash From Operating Activities	6.211M	6.918M	15.50M
Cash From Investing Activities	-2.855M	-18.72M	-10.74M
Cash From Financing Activities	-3.189M	10.81M	-5.568M
Net Change In Cash	166.8K	-993.9K	-804.1K
YoY Change	-98.75%	-7.53%	-77.76%
FREE CASH FLOW
Cash From Operating Activities	$6.211M	$6.918M	$15.50M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13853334
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	8730003
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	10692349
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	477756
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	908873
CY2024Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	3008593
CY2023Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	2256228
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	380279
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001867949
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	refi	Change In Unrealized Loss On Debt Securities At Fair Value ChangeInUnrealizedLossOnDebtSecuritiesAtFairValue
CY2023Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss
CY2024Q1	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear
CY2024Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths
CY2024Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear
CY2024Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear
CY2024Q1	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41123
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-3125132
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1680 Michigan Avenue
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami Beach
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33139
CY2024Q1	dei	City Area Code CityAreaCode	(312)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	809-7002
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2024Q1	dei	Trading Symbol TradingSymbol	REFI
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Bankruptcy Proceedings Reporting Current EntityBankruptcyProceedingsReportingCurrent	true
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19100282
CY2024Q1	refi	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossInvestment	359317126
CY2023Q4	refi	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossInvestment	337238122
CY2024Q1	refi	Loan Held For Investment Related Party LoanHeldForInvestmentRelatedParty	16527188
CY2023Q4	refi	Loan Held For Investment Related Party LoanHeldForInvestmentRelatedParty	16402488
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	375844314
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	353640610
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	5356018
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Loss Excluding Accrued Interest FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest	4972647
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	370488296
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss	348667963
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6904113
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7898040
CY2024Q1	us-gaap	Other Receivables OtherReceivables	5143318
CY2023Q4	us-gaap	Other Receivables OtherReceivables	705960
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	926852
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1004140
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	192354
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	107225
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	842269
CY2024Q1	us-gaap	Assets Assets	383654933
CY2023Q4	us-gaap	Assets Assets	359225597
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	81250000
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	66000000
CY2024Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9007244
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	13866656
CY2024Q1	us-gaap	Other Liabilities OtherLiabilities	1819428
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	3243775
CY2024Q1	us-gaap	Management Fee Payable ManagementFeePayable	1754741
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	2051531
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1342872
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1135355
CY2024Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	2519871
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1074889
CY2024Q1	us-gaap	Liabilities Liabilities	97694156
CY2023Q4	us-gaap	Liabilities Liabilities	87372206
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19100282
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19100282
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18197192
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18197192
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	191003
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	181972
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	291858521
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	277483092
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6088747
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5811673
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	285960777
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	271853391
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	383654933
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	359225597
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	15343667
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	16527304
CY2024Q1	us-gaap	Interest Expense InterestExpense	2104050
CY2023Q1	us-gaap	Interest Expense InterestExpense	1618296
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	13239617
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14909008
CY2024Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	1754741
CY2023Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	2138005
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1390267
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1274825
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	449858
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	569375
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	531293
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	138335
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	380279
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	96119
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	4506438
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	4216659
CY2024Q1	refi	Change In Unrealized Loss On Debt Securities At Fair Value ChangeInUnrealizedLossOnDebtSecuritiesAtFairValue	75604
CY2024Q1	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	72428
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8730003
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10692349
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	8730003
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	10692349
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.6
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.6
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18273919
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17879444
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18640492
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17960103
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	271853391
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13853334
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	531293
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	9007244
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	8730003
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	285960777
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	264033023
CY2023Q1	refi	Stock Issued During Period Connection With Initial Public Offering And Concurrent Private Placement Net Of Offering Costs Underwritting Discount And Commission StockIssuedDuringPeriodConnectionWithInitialPublicOfferingAndConcurrentPrivatePlacementNetOfOfferingCostsUnderwrittingDiscountAndCommission	5794917
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	138335
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.47
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	8535296
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	10692349
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	272123328
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	8730003
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	96119
CY2024Q1	refi	Change In Unrealized Gainloss On Debt Securities Available For Sale At Fair Value ChangeInUnrealizedGainlossOnDebtSecuritiesAvailableForSaleAtFairValue	75604
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	10692349
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	477756
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	908873
CY2024Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	3008593
CY2023Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	2256228
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	380279
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	96119
CY2024Q1	refi	Change In Unrealized Gainloss On Debt Securities Available For Sale At Fair Value ChangeInUnrealizedGainlossOnDebtSecuritiesAvailableForSaleAtFairValue	75604
CY2024Q1	refi	Realized Gain Loss On Debt Securities At Fair Value RealizedGainLossOnDebtSecuritiesAtFairValue	72428
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	167304
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	138335
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-77288
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	2955336
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	97151
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19507
CY2024Q1	refi	Increase Decrease In Interest Reserves IncreaseDecreaseInInterestReserves	1444982
CY2023Q1	refi	Increase Decrease In Interest Reserves IncreaseDecreaseInInterestReserves	-1648129
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-296790
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-127389
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	85129
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	237885
CY2024Q1	refi	Proceeds From The Redemption Of Debt Securities At Fair Value ProceedsFromTheRedemptionOfDebtSecuritiesAtFairValue	839094
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1424347
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1157595
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210608
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-81098
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6917872
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1702067
CY2024Q1	refi	Issuance Of And Fundings Of Loans Held For Investment IssuanceOfAndFundingsOfLoansHeldForInvestment	22380807
CY2023Q1	refi	Issuance Of And Fundings Of Loans Held For Investment IssuanceOfAndFundingsOfLoansHeldForInvestment	32941660
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	13399712
CY2024Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	3663452
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	44858834
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18717355
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25316886
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9811862
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000010
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	28000000
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	28500000
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	12750000
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	49000000
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	13866656
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	13486186
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	49738
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2988
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	339912
CY2024Q1	refi	Realized Gain Loss On Debt Securities At Fair Value RealizedGainLossOnDebtSecuritiesAtFairValue	72428
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	90915
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	167304
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	531293
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	138335
CY2024Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	97151
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	19507
CY2024Q1	refi	Increase Decrease In Interest Reserves IncreaseDecreaseInInterestReserves	1444982
CY2023Q1	refi	Increase Decrease In Interest Reserves IncreaseDecreaseInInterestReserves	-1648129
CY2024Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-296790
CY2023Q1	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-127389
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	85129
CY2024Q1	refi	Proceeds From The Redemption Of Debt Securities At Fair Value ProceedsFromTheRedemptionOfDebtSecuritiesAtFairValue	839094
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1424347
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	210608
CY2024Q1	refi	Issuance Of And Fundings Of Loans Held For Investment IssuanceOfAndFundingsOfLoansHeldForInvestment	22380807
CY2023Q1	refi	Issuance Of And Fundings Of Loans Held For Investment IssuanceOfAndFundingsOfLoansHeldForInvestment	32941660
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	13399712
CY2024Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	3663452
CY2023Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	44858834
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18717355
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25316886
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9811862
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000010
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	28000000
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	28500000
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	49738
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2988
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	339912
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	104711
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10805556
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28093875
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-993927
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7898040
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5715827
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6904113
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4640905
CY2024Q1	refi	Interest Reserve Withheld From Funding Of Loans InterestReserveWithheldFromFundingOfLoans	2032688
CY2024Q1	refi	Oid Withheld From Funding Of Loans Held For Investment OIDWithheldFromFundingOfLoansHeldForInvestment	105081
CY2023Q1	refi	Oid Withheld From Funding Of Loans Held For Investment OIDWithheldFromFundingOfLoansHeldForInvestment	1118340
CY2024Q1	refi	Subscription Receivable From Sale Of Common Stock SubscriptionReceivableFromSaleOfCommonStock	4472690
CY2023Q1	us-gaap	Mortgage Loan Related To Property Sales1 MortgageLoanRelatedToPropertySales1	13399712
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1786333
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.90
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	104711
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10805556
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-28093875
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-993927
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1074922
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7898040
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5715827
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6904113
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4640905
CY2024Q1	refi	Interest Reserve Withheld From Funding Of Loans InterestReserveWithheldFromFundingOfLoans	2032688
CY2024Q1	refi	Oid Withheld From Funding Of Loans Held For Investment OIDWithheldFromFundingOfLoansHeldForInvestment	105081
CY2023Q1	refi	Oid Withheld From Funding Of Loans Held For Investment OIDWithheldFromFundingOfLoansHeldForInvestment	1118340
CY2024Q1	refi	Subscription Receivable From Sale Of Common Stock SubscriptionReceivableFromSaleOfCommonStock	4472690
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9007244
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8667701
CY2023Q1	us-gaap	Mortgage Loan Related To Property Sales1 MortgageLoanRelatedToPropertySales1	13399712
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	1786333
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1363742
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.90
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6900000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7900000
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates in the Preparation of Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.</span></p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6900000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7900000
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates in the Preparation of Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.</span></p>
CY2024Q1	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest income on debt securities designated as trading securities is recognized on an accrual basis and is reported as interest receivable until collected. Interest income is accrued based on the outstanding face amount and the contractual terms of the securities. Original issue discount (“OID”), market discounts or premiums, if any, are recorded as an adjustment to the amortized cost and accreted or amortized as an adjustment to interest income using a method that approximates the effective interest method. Realized gains or losses on debt securities are measured by the difference between the net proceeds from the disposition and the amortized and/or accreted cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include loans charged off during the period, net of recoveries.</span></p>
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.90
CY2024Q1	refi	Effective Income Tax Rate Capital Gain Net Income EffectiveIncomeTaxRateCapitalGainNetIncome	0.95
CY2024Q1	refi	Effective Income Tax Rate Reconciliation Non Deductible Excise Tax EffectiveIncomeTaxRateReconciliationNonDeductibleExciseTax	0.04
CY2024Q1	refi	Effective Income Tax Rate Reconciliation Distribution Of Net Capital Gains EffectiveIncomeTaxRateReconciliationDistributionOfNetCapitalGains	0.90
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04
CY2024Q1	refi	Principal New Fundings PrincipalNewFundings	22400000
CY2024Q1	refi	Portfolio Percentage PortfolioPercentage	0.766
CY2023Q4	refi	Portfolio Percentage PortfolioPercentage	0.805
CY2024Q1	us-gaap	Debt Current DebtCurrent	287700000
CY2023Q4	us-gaap	Debt Current DebtCurrent	284500000
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.234
CY2024Q1	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest income on debt securities designated as trading securities is recognized on an accrual basis and is reported as interest receivable until collected. Interest income is accrued based on the outstanding face amount and the contractual terms of the securities. Original issue discount (“OID”), market discounts or premiums, if any, are recorded as an adjustment to the amortized cost and accreted or amortized as an adjustment to interest income using a method that approximates the effective interest method. Realized gains or losses on debt securities are measured by the difference between the net proceeds from the disposition and the amortized and/or accreted cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include loans charged off during the period, net of recoveries.</span></p>
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.90
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	1
CY2024Q1	refi	Effective Of Ordinary Income Percentage EffectiveOfOrdinaryIncomePercentage	0.85
CY2024Q1	refi	Effective Income Tax Rate Capital Gain Net Income EffectiveIncomeTaxRateCapitalGainNetIncome	0.95
CY2024Q1	refi	Effective Income Tax Rate Reconciliation Non Deductible Excise Tax EffectiveIncomeTaxRateReconciliationNonDeductibleExciseTax	0.04
CY2024Q1	refi	Effective Income Tax Rate Reconciliation Distribution Of Net Capital Gains EffectiveIncomeTaxRateReconciliationDistributionOfNetCapitalGains	0.90
CY2024Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04
CY2024Q1	refi	Portfolio Percentage PortfolioPercentage	0.766
CY2023Q4	refi	Portfolio Percentage PortfolioPercentage	0.805
CY2024Q1	us-gaap	Debt Current DebtCurrent	287700000
CY2023Q4	us-gaap	Debt Current DebtCurrent	284500000
CY2024Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.234
CY2023Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.195
CY2024Q1	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	88100000
CY2023Q4	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	69100000
CY2024Q1	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	377576334
CY2024Q1	refi	Senior Term Loans Original Issue Discount SeniorTermLoansOriginalIssueDiscount	-1732020
CY2024Q1	refi	Senior Term Loans Principal SeniorTermLoansPrincipal	375844314
CY2024Q1	us-gaap	Financing Receivable Modified Weighted Average Term Increase From Modification FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification	P2Y
CY2024Q1	refi	Current Expected Credit Loss Reserve Principal CurrentExpectedCreditLossReservePrincipal	0
CY2024Q1	refi	Current Expected Credit Loss Reserve Original Discount CurrentExpectedCreditLossReserveOriginalDiscount	0
CY2024Q1	refi	Current Expected Credit Loss Reserve Carrying Values CurrentExpectedCreditLossReserveCarryingValues	-5356018
CY2024Q1	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	377576334
CY2024Q1	refi	Loans Held At Original Issue Discount LoansHeldAtOriginalIssueDiscount	-1732020
CY2024Q1	refi	Loans Held At Principal Value LoansHeldAtPrincipalValue	370488296
CY2023Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	355745305
CY2023Q4	refi	Senior Term Loans Original Issue Discount SeniorTermLoansOriginalIssueDiscount	-2104695
CY2023Q4	refi	Senior Term Loans Principal SeniorTermLoansPrincipal	353640610
CY2023	us-gaap	Financing Receivable Modified Weighted Average Term Increase From Modification FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification	P2Y1M6D
CY2023Q4	refi	Current Expected Credit Loss Reserve Principal CurrentExpectedCreditLossReservePrincipal	0
CY2023Q4	refi	Current Expected Credit Loss Reserve Original Discount CurrentExpectedCreditLossReserveOriginalDiscount	0
CY2023Q4	refi	Current Expected Credit Loss Reserve Carrying Values CurrentExpectedCreditLossReserveCarryingValues	-4972647
CY2023Q4	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	355745305
CY2023Q4	refi	Loans Held At Original Issue Discount LoansHeldAtOriginalIssueDiscount	-2104695
CY2023Q4	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.195
CY2024Q1	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	88100000
CY2023Q4	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	69100000
CY2024Q1	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	377576334
CY2024Q1	refi	Senior Term Loans Principal SeniorTermLoansPrincipal	375844314
CY2024Q1	us-gaap	Financing Receivable Modified Weighted Average Term Increase From Modification FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification	P2Y
CY2024Q1	refi	Current Expected Credit Loss Reserve Principal CurrentExpectedCreditLossReservePrincipal	0
CY2024Q1	refi	Current Expected Credit Loss Reserve Carrying Values CurrentExpectedCreditLossReserveCarryingValues	-5356018
CY2024Q1	us-gaap	Principal Amount Outstanding Of Loans Held In Portfolio PrincipalAmountOutstandingOfLoansHeldInPortfolio	377576334
CY2024Q1	refi	Loans Held At Original Issue Discount LoansHeldAtOriginalIssueDiscount	-1732020
CY2024Q1	refi	Loans Held At Principal Value LoansHeldAtPrincipalValue	370488296
CY2023Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	355745305
CY2023Q4	refi	Senior Term Loans Original Issue Discount SeniorTermLoansOriginalIssueDiscount	-2104695
CY2023Q4	refi	Senior Term Loans Principal SeniorTermLoansPrincipal	353640610
CY2023Q4	refi	Current Expected Credit Loss Reserve Original Discount CurrentExpectedCreditLossReserveOriginalDiscount	0
CY2023Q4	refi	Loans Held At Original Issue Discount LoansHeldAtOriginalIssueDiscount	-2104695
CY2023Q4	refi	Loans Held At Principal Value LoansHeldAtPrincipalValue	348667963
CY2023Q4	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	348667963
CY2024Q1	refi	New Fundings NewFundings	22380807
CY2024Q1	refi	Principal Repayment Of Loans And Principal Receivables PrincipalRepaymentOfLoansAndPrincipalReceivables	3663452
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	477756
CY2024Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	3008593
CY2024Q1	us-gaap	Provision For Other Losses ProvisionForOtherLosses	383371
CY2024Q1	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	370488296
CY2022Q4	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	335332599
CY2023Q1	refi	New Fundings NewFundings	32941660
CY2023Q1	refi	Principal Repayment Of Loans And Principal Receivables PrincipalRepaymentOfLoansAndPrincipalReceivables	45754443
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	908873
CY2023Q1	refi	Principal Sale Of Loans PrincipalSaleOfLoans	13399712
CY2023Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	2256228
CY2023Q1	us-gaap	Provision For Other Losses ProvisionForOtherLosses	110995
CY2023Q1	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	312174210
CY2024Q1	refi	Loan Commitment LoanCommitment	401257040
CY2024Q1	refi	Outstanding Principal OutstandingPrincipal	377576334
CY2024Q1	refi	Original Issue Premium Discount OriginalIssuePremiumDiscount	-1732020
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	375844314
CY2024Q1	refi	Percentof Our Loan Portfolio PercentofOurLoanPortfolio	1
CY2024Q1	refi	Yieldto Maturityof Internal Rateof Return YieldtoMaturityofInternalRateofReturn	0.194
CY2024Q1	us-gaap	Loans Payable LoansPayable	1
CY2023Q4	us-gaap	Loans Payable LoansPayable	2
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	375844314
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	54606866
CY2023Q4	refi	Loans Held At Principal Value LoansHeldAtPrincipalValue	348667963
CY2023Q4	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	348667963
CY2024Q1	refi	New Fundings NewFundings	22380807
CY2024Q1	refi	Principal Repayment Of Loans And Principal Receivables PrincipalRepaymentOfLoansAndPrincipalReceivables	3663452
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	477756
CY2024Q1	us-gaap	Interest Income Operating Paid In Kind InterestIncomeOperatingPaidInKind	3008593
CY2024Q1	us-gaap	Provision For Other Losses ProvisionForOtherLosses	383371
CY2024Q1	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	370488296
CY2022Q4	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	335332599
CY2023Q1	refi	New Fundings NewFundings	32941660
CY2023Q1	us-gaap	Provision For Other Losses ProvisionForOtherLosses	110995
CY2023Q1	refi	Loan Held At Carrying Value Balance LoanHeldAtCarryingValueBalance	312174210
CY2024Q1	refi	Loan Commitment LoanCommitment	401257040
CY2024Q1	refi	Outstanding Principal OutstandingPrincipal	377576334
CY2024Q1	refi	Original Issue Premium Discount OriginalIssuePremiumDiscount	-1732020
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent	375844314
CY2024Q1	refi	Percentof Our Loan Portfolio PercentofOurLoanPortfolio	1
CY2024Q1	refi	Yieldto Maturityof Internal Rateof Return YieldtoMaturityofInternalRateofReturn	0.194
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	375844314
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	375844314
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	353640610
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	353640610
CY2024Q1	us-gaap	Loans Payable LoansPayable	1
CY2023Q4	us-gaap	Loans Payable LoansPayable	2
CY2024Q1	refi	Financing Receivable Excluding Accrued Interest Year One Remainding Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneRemaindingFiscalYear	7653078
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	65128214
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	152915100
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	150147921
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	375844314
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	54606866
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	149948641
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	149085103
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	0
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	353640610
CY2024Q1	refi	Financing Receivable Excluding Accrued Interest Year One Remainding Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneRemaindingFiscalYear	7653078
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear	65128214
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	152915100
CY2024Q1	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	150147921
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear	149948641
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear	149085103
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear	0
CY2023Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss	353640610
CY2024Q1	refi	Real Estate Collaterals Coverage RealEstateCollateralsCoverage	375844314
CY2023Q4	refi	Real Estate Collaterals Coverage RealEstateCollateralsCoverage	353640610
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	4975739
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	380279
CY2024Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	5356018
CY2022Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	4035354
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	96119
CY2023Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	4131473
CY2024Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	895852
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	973140
CY2024Q1	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	31000
CY2023Q4	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	31000
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	926852
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1004140
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	926852
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	926852
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1004140
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1004140
CY2023Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	16300000
CY2024Q1	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	0
CY2024Q1	refi	Real Estate Collaterals Coverage RealEstateCollateralsCoverage	375844314
CY2023Q4	refi	Real Estate Collaterals Coverage RealEstateCollateralsCoverage	353640610
CY2023Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	4975739
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	380279
CY2024Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	5356018
CY2022Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	4035354
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	96119
CY2023Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount Covered LoansAndLeasesReceivableGrossCarryingAmountCovered	4131473
CY2024Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	895852
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	973140
CY2024Q1	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	31000
CY2023Q4	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	31000
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	926852
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1004140
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	926852
CY2024Q1	us-gaap	Interest Receivable InterestReceivable	926852
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1004140
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	1004140
CY2023Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	16300000
CY2024Q1	us-gaap	Financing Receivable Accrued Interest Writeoff FinancingReceivableAccruedInterestWriteoff	0
CY2023Q4	refi	Interest Reserves InterestReserves	1074889
CY2022Q4	refi	Interest Reserves InterestReserves	1868193
CY2024Q1	refi	New Reserves NewReserves	2032688
CY2023	refi	Reserve Disbursed ReserveDisbursed	3031652
CY2023Q4	refi	Interest Reserves InterestReserves	1074889
CY2024Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	100000
CY2023Q2	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	2988
CY2024Q1	refi	Debt Instrument Covenants Maximum Capital Expenditures DebtInstrumentCovenantsMaximumCapitalExpenditures	150000
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	325415
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	366592
CY2024Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	81300000
CY2024Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan During Period FinancingReceivableRevolvingConvertedToTermLoanDuringPeriod	18700000
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2007050
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1440992
CY2024Q1	refi	Unused Fee Expense UnusedFeeExpense	6085
CY2023Q1	refi	Unused Fee Expense UnusedFeeExpense	10000
CY2024Q1	refi	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	90915
CY2023Q1	refi	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	167304
CY2024Q1	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	-2104050
CY2023Q1	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	-1618296
CY2024Q1	us-gaap	Management Fee Description ManagementFeeDescription	The Manager is entitled to receive base management fees (the “Base Management Fee”) that are calculated and payable quarterly in arrears, in an amount equal to 0.375% of the Company’s Equity, determined as of the last day of each such quarter; reduced by an amount equal to 50% of the pro rata amount of origination fees earned and paid to the Manager during the applicable quarter for loans that were originated on the Company’s behalf by the Manager or affiliates of the Manager (“Outside Fees”).
CY2024Q1	refi	Outside Fees Earned OutsideFeesEarned	16071
CY2023Q1	refi	Outside Fees Earned OutsideFeesEarned	5000
CY2024Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	696504
CY2023Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1111206
CY2023Q4	refi	Interest Reserves InterestReserves	1074889
CY2022Q4	refi	Interest Reserves InterestReserves	1868193
CY2024Q1	refi	New Reserves NewReserves	2032688
CY2023	refi	New Reserves NewReserves	2238348
CY2024Q1	refi	Reserve Disbursed ReserveDisbursed	587706
CY2023	refi	Reserve Disbursed ReserveDisbursed	3031652
CY2024Q1	refi	Interest Reserves InterestReserves	2519871
CY2023Q4	refi	Interest Reserves InterestReserves	1074889
CY2024Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	100000
CY2023Q2	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	2988
CY2024Q1	refi	Debt Instrument Covenants Maximum Capital Expenditures DebtInstrumentCovenantsMaximumCapitalExpenditures	150000
CY2024Q1	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	325415
CY2023Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	366592
CY2024Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	81300000
CY2024Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan During Period FinancingReceivableRevolvingConvertedToTermLoanDuringPeriod	18700000
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2007050
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1440992
CY2024Q1	refi	Unused Fee Expense UnusedFeeExpense	6085
CY2023Q1	refi	Unused Fee Expense UnusedFeeExpense	10000
CY2024Q1	refi	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	90915
CY2023Q1	refi	Amortization Of Deferred Financing Costs AmortizationOfDeferredFinancingCosts	167304
CY2024Q1	us-gaap	Interest Revenue Expense Net InterestRevenueExpenseNet	-2104050
CY2024Q1	refi	Management Fees Earned ManagementFeesEarned	1074308
CY2023Q1	refi	Management Fees Earned ManagementFeesEarned	1031799
CY2024Q1	refi	Outside Fees Earned OutsideFeesEarned	16071
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1026799
CY2024Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	696504
CY2023Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1111206
CY2024Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	1754741
CY2023Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	2138005
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1237790
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1176376
CY2024Q1	us-gaap	Affiliate Costs AffiliateCosts	2992531
CY2023Q1	us-gaap	Affiliate Costs AffiliateCosts	3314381
CY2024Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	3600000
CY2023	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	5300000
CY2024Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	800000
CY2024Q1	refi	Assigned Right Sold Amount AssignedRightSoldAmount	0
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	19300000
CY2023Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	19000000
CY2024Q1	us-gaap	Other Commitment OtherCommitment	81250000
CY2024Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	81250000
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	417
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	5677200
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	1073937
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	5525370
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	937068
CY2024Q1	refi	Management Fees Earned ManagementFeesEarned	1074308
CY2023Q1	refi	Management Fees Earned ManagementFeesEarned	1031799
CY2024Q1	refi	Outside Fees Earned OutsideFeesEarned	16071
CY2023Q1	refi	Outside Fees Earned OutsideFeesEarned	5000
CY2024Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1058237
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	1026799
CY2024Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	696504
CY2023Q1	us-gaap	Incentive Fee Expense IncentiveFeeExpense	1111206
CY2024Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	1754741
CY2023Q1	refi	Management And Incentive Fees Payable ManagementAndIncentiveFeesPayable	2138005
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1237790
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1176376
CY2023Q1	us-gaap	Affiliate Costs AffiliateCosts	3314381
CY2024Q1	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	3600000
CY2023	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	5300000
CY2024Q1	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	800000
CY2023Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	1200000
CY2024Q1	refi	Assigned Right Sold Amount AssignedRightSoldAmount	0
CY2023Q1	refi	Assigned Right Sold Amount AssignedRightSoldAmount	0
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	19300000
CY2023Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	19000000
CY2024Q1	us-gaap	Selling Expense SellingExpense	14200000
CY2024Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	13400000
CY2024Q1	us-gaap	Loans Payable Current LoansPayableCurrent	16500000
CY2024Q1	refi	Original Loan Commitments OriginalLoanCommitments	401257040
CY2023Q4	refi	Original Loan Commitments OriginalLoanCommitments	378849998
CY2024Q1	refi	Less Drawn Commitments LessDrawnCommitments	401257040
CY2023Q4	refi	Less Drawn Commitments LessDrawnCommitments	371349998
CY2024Q1	refi	Undrawn Commitments UndrawnCommitments	0
CY2023Q4	refi	Undrawn Commitments UndrawnCommitments	7500000
CY2024Q1	us-gaap	Other Commitment OtherCommitment	81250000
CY2024Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	81250000
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	417
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	5677200
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	5525370
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	937068
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	366647
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.86
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6647
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	16
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	360000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.84
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	16
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	417
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	16
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	73615
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.68
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	531293
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	138335
CY2024Q1	refi	Unamortized Share Based Compensation Expense UnamortizedShareBasedCompensationExpense	4000000
CY2023Q1	refi	Unamortized Share Based Compensation Expense UnamortizedShareBasedCompensationExpense	1100000
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	75000000
CY2024Q1	refi	Gross Proceeds Percentage grossProceedsPercentage	0.03
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.6
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	366647
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.86
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6647
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	16
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	360000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	14.84
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	80984
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.71
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6952
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	16
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	417
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	16
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	73615
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.68
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	531293
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	138335
CY2024Q1	refi	Unamortized Share Based Compensation Expense UnamortizedShareBasedCompensationExpense	4000000
CY2023Q1	refi	Unamortized Share Based Compensation Expense UnamortizedShareBasedCompensationExpense	1100000
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y10M24D
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	75000000
CY2024Q1	refi	Gross Proceeds Percentage grossProceedsPercentage	0.03
CY2024Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	8730003
CY2023Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	10692349
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18273919
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17879444
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18640492
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17960103
CY2024Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	8730003
CY2023Q1	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	10692349
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18273919
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17879444
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18640492
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17960103
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.48
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.6
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.47
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.6
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Income Tax Holiday Description IncomeTaxHolidayDescription	To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute annually to our stockholders at least 90% of our REIT taxable income prior to the deduction for dividends paid. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of 1) 85% of our ordinary income for the calendar year, 2) 95% of our capital gain net income for the calendar year, and 3) any undistributed shortfall from our prior calendar year (the “Required Distribution”) to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. Our stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax.
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	842269
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	373256778
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	351952876
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-2587536
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1687734
CY2024Q1	us-gaap	Income Tax Holiday Description IncomeTaxHolidayDescription	To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute annually to our stockholders at least 90% of our REIT taxable income prior to the deduction for dividends paid. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of 1) 85% of our ordinary income for the calendar year, 2) 95% of our capital gain net income for the calendar year, and 3) any undistributed shortfall from our prior calendar year (the “Required Distribution”) to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. Our stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax.
CY2023Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	842269
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	351952876
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-2587536
CY2023	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1687734
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	refi	Non Rule10 B51 Arr Modified Flag NonRule10B51ArrModifiedFlag	false
CY2024Q1	refi	Rule10 B51 Arr Modified Flag Rule10B51ArrModifiedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
refi-20240331.htm	Edgar Link	pending
refi-20240331.xsd	Edgar Link	pending
refi-ex31_1.htm	Edgar Link	pending
refi-ex31_2.htm	Edgar Link	pending
refi-ex32_1.htm	Edgar Link	pending
refi-ex32_2.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
0000950170-24-053919-index-headers.html	Edgar Link	pending
0000950170-24-053919-index.html	Edgar Link	pending
0000950170-24-053919.txt	Edgar Link	pending
0000950170-24-053919-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
refi-20240331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REFI
Chicago Atlantic Real Estate Finance, Inc. Stock $refi

2024 Q2 Form 10-Q Financial Statement

#000095017024053919 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REFI Chicago Atlantic Real Estate Finance, Inc. Stock $refi

2024 Q2 Form 10-Q Financial Statement

#000095017024053919 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REFI
Chicago Atlantic Real Estate Finance, Inc. Stock $refi